Intraosseous Basivertebral Nerve Ablation for Chronic Back Pain
Current Guideline Recommendations
- Current neurosurgical guidelines explicitly state there is "insufficient evidence" for the effectiveness of the Intracept System (intraosseous basivertebral nerve ablation) for the treatment of low back pain 1, 2, 3.
- The 2014 guidelines for fusion procedures for degenerative disease of the lumbar spine do not include basivertebral nerve ablation as a recommended treatment option 1.
- Even established interventional procedures like epidural steroid injections only have weak evidence (Level III) for short-term relief of pain in patients with chronic low back pain from degenerative lumbar disease 1.
- For facet-mediated chronic low back pain, there is only moderate evidence (Level II) that facet medial nerve ablation produces short-term decrease (3-6 months) of pain 1.
Treatment Alternatives with Established Evidence
- The American Academy of Neurosurgery recommends lumbar epidural injections, facet injections, or trigger point injections may provide temporary symptomatic relief in selected patients with chronic low back pain 2, 3, 4.
- However, these are not recommended for long-term relief 2, 3, 4.
- The British Medical Journal clinical practice guideline indicates that interventional procedures for chronic spine pain are costly and may be associated with risks including prolonged pain/stiffness (8.6%), temporary altered consciousness (2.1%), dural puncture (1.4%), and deep infection (0.7%) 5.
- There is also a very small risk of catastrophic harms such as infection resulting in meningitis, spinal cord injury, and paraplegia 5.
Clinical Decision Making
- For patients with chronic back pain due to degenerative disc disease, the requested procedure (intraosseous basivertebral nerve ablation) is classified as having "insufficient evidence" 1, 2, 3.
- The cost-benefit ratio is unfavorable given the substantial costs of interventional procedures (up to $5000 per procedure in the US) and uncertain benefits 5.